Read more about Stephen McNeill, if you like.
Stephen is a Partner in our Corporate and Commercial Team, based predominantly in our London office. He advises UK and international businesses, investors, entrepreneurs and management teams on a broad range of corporate and commercial matters, with particular expertise in cross-border mergers and acquisitions, private equity and venture capital investments, joint ventures, corporate restructurings, shareholder arrangements and strategic commercial transactions.
Stephen has significant experience advising clients across a range of sectors, including pharmaceuticals, biotechnology, medical technology, technology and SaaS, financial services and sport. His practice spans the full corporate lifecycle, from early-stage investment and business expansion through to complex acquisitions, disposals, international restructurings and strategic exits.
He has a particular focus on the pharmaceutical and life sciences sectors, advising businesses and investors on acquisitions, investments, corporate structuring and the commercial arrangements underpinning international operations. His experience includes pharmaceutical product and business acquisitions, licensing and technology transfers, manufacturing and supply agreements, joint ventures and international expansion.
Stephen also has longstanding relationships across the Nordic markets, particularly Iceland, having previously served as Partner and Head of the London office of LOGOS Legal Services, one of Iceland’s leading law firms. He regularly works with international clients and professional advisers on transactions involving the UK, Europe and other jurisdictions, helping businesses navigate the legal and commercial challenges of operating across borders.
Before joining Sherrards, Stephen also practised in the London offices of leading international law firms Milbank LLP and Orrick, Herrington & Sutcliffe LLP, developing extensive experience in international corporate transactions, private equity and complex commercial matters.
A notable example of Stephen’s experience is his longstanding relationship with Kerecis, the Icelandic medical technology business specialising in regenerative tissue products. Stephen worked closely with Kerecis over several years, including a period working in-house with the business, advising on corporate, commercial, intellectual property, licensing and compliance matters, and subsequently in connection with its US$1.3 billion sale to Coloplast in 2023, one of Iceland’s most significant international business exits.
Alongside his transactional practice, Stephen advises clients on ongoing corporate governance, commercial contracts, shareholder matters and strategic business decisions, frequently acting as a trusted adviser to founders, investors and management teams.
Stephen also has experience advising clients in the sports sector, including football clubs, players and other sporting organisations, and is a member of Sherrards’ Sports Group. His work has included player contracts, commercial arrangements, corporate matters and transactions involving professional football clubs.
He is particularly valued for his commercially focused and pragmatic approach, his ability to coordinate complex cross-border matters and his commitment to developing longstanding relationships with clients.
Enough about Stephen, now over to you.